United States Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The United States Drug Delivery Devices Market is Segmented by Route of Administration (Topical, Injectable, Oral, and Other Routes of Administration), Application (Cancer, Cardiovascular, Diabetes, and Other Applications), and End Users (Hospitals, Ambulatory Surgical Centres, and Other End Users). The report offers the value (in USD million) for the above segments.

United States Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

USA Drug Delivery Devices Industry Overview

The US drug delivery devices market is highly competitive. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known. Many of these companies are undertaking various strategies to maintain their market shares. The key players in the market are Bayer AG, Johnson & Johnson Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc., Sanofi, Abbott Laboratories, and 3M.

USA Drug Delivery Devices Market Leaders

  1. Bayer AG

  2. F. Hoffmann-La Roche Ltd

  3. Johnson & Johnson

  4. Novartis AG

  5. GSK PLC

  6. *Disclaimer: Major Players sorted in no particular order
United States Drug Delivery Devices Market Concentration

United States Drug Delivery Devices Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?